Patients Seek Revival Of Diabetes Drug Claims In 9th Circ.
Consumers on Wednesday pushed the Ninth Circuit to revive state-law claims that Merck and other drugmakers failed to warn them of pancreas problems from Type 2 diabetes drugs, saying that a...To view the full article, register now.
Already a subscriber? Click here to view full article